Peabody Developmental Motor Scaling In Children With Period Duchenne Muscular Dystrophy

Sponsor
Ondokuz Mayıs University (Other)
Overall Status
Completed
CT.gov ID
NCT05990608
Collaborator
(none)
48
1
24
2

Study Details

Study Description

Brief Summary

To perform the reliability and validity study of the Peabody Developmental Motor Scale (Peabody Developmental Motor Scales-2) in children with Duchenne Muscular Dystrophy (DMD).

Condition or Disease Intervention/Treatment Phase
  • Other: Peabody Developmental Motor Scales-2, PDMS

Study Design

Study Type:
Observational
Actual Enrollment :
48 participants
Observational Model:
Other
Time Perspective:
Other
Official Title:
The Validity and Reliability of The Peabody Developmental Motor Score In Children With Preschool Duchenne Muscular Dystrophy
Actual Study Start Date :
Jul 30, 2021
Actual Primary Completion Date :
Jul 30, 2022
Actual Study Completion Date :
Jul 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Group I

Healthy Children

Other: Peabody Developmental Motor Scales-2, PDMS
The Peabody Developmental Engine Scales-2, PDMS, is a standardized norm-referenced test used to determine the motor skill level of children aged 0 to 6, identify delays in engine development, and determine individual needs and challenges. The 2 scalar, which allows children to evaluate rough and thin motor skills, consists of 6 sub-tests and 249 articles. The rough motor scale contains 4 sub-tests and 151 items, including reflex, equilibrium, locomotion and object manipulation. The slim motor scale consists of 2 sub-tests and 98 items, including cognition and visual-motor integration. Using the age-appropriate normal value ranges in the test manual to determine developmental stress risk and level, the coarse motor skills, slim motor skills, and general motor development are categorized as "very low, low, below average, above average, high, very high".

Group II

Children with DMD

Other: Peabody Developmental Motor Scales-2, PDMS
The Peabody Developmental Engine Scales-2, PDMS, is a standardized norm-referenced test used to determine the motor skill level of children aged 0 to 6, identify delays in engine development, and determine individual needs and challenges. The 2 scalar, which allows children to evaluate rough and thin motor skills, consists of 6 sub-tests and 249 articles. The rough motor scale contains 4 sub-tests and 151 items, including reflex, equilibrium, locomotion and object manipulation. The slim motor scale consists of 2 sub-tests and 98 items, including cognition and visual-motor integration. Using the age-appropriate normal value ranges in the test manual to determine developmental stress risk and level, the coarse motor skills, slim motor skills, and general motor development are categorized as "very low, low, below average, above average, high, very high".

Outcome Measures

Primary Outcome Measures

  1. Peabody Developmental Motor Scales-2 [This assessment will take place over the course of the study started and to the finish time]

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 5 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • for Group I:

  • No neurodevelopmental problems or diseases

  • 3-5 years old

  • Being able to cooperate with the instructions given by the physiotherapist.

  • Children who volunteered to participate in the study and whose families gave consent form will be included in the study.

  • for Group II:

  • Being diagnosed with Duchenne Muscular Dystrophy by a pediatric neurologist

  • 3-5 years old

  • Children who volunteered to participate in the study and whose parents' consent was obtained will be included in the study.

Exclusion Criteria:
  • Children with a behavioral condition and any disorder that interferes with testing (eg autism spectrum disorder)

  • Failure to cooperate with the physiotherapist who made the evaluations.

  • Lack of volunteers.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ondokuz Mayıs University Samsun Turkey 55270

Sponsors and Collaborators

  • Ondokuz Mayıs University

Investigators

  • Principal Investigator: Deniz Çakır, Ondokuz Mayıs University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Deniz Çakır, Research Assistant, Ondokuz Mayıs University
ClinicalTrials.gov Identifier:
NCT05990608
Other Study ID Numbers:
  • 2021/371
First Posted:
Aug 14, 2023
Last Update Posted:
Aug 14, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Deniz Çakır, Research Assistant, Ondokuz Mayıs University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 14, 2023